Showing 1011-1020 of 3017 results for "".
Free Cartilage-Mucosa Composite Graft for Closure of Nasal Septal Perforations
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/free-cartilage-mucosa-composite-graft-for-closure-of-nasal-septal-perforations/23192/The majority of NSP repairs are not performed by community dermatologists and cosmetic surgeons, but a simple technique could change that.Dermatology Patients Ask Google. But Who Answers?
https://practicaldermatology.com/topics/practice-management/dermatology-patients-ask-google-but-who-answers/23165/Despite dermatologists’ expertise, their sites may not rank highest in search for skin health topics.A Growing Armamentarium for Psoriasis: How to Choose the Right Treatment for Each Patient
https://practicaldermatology.com/topics/psoriasis/a-growing-armamentarium-for-psoriasis-how-to-choose-the-right-treatment-for-each-patient/18214/Erin Boh, MD joins host Joshua Zeichner, MD in this edition of DermTube Journal Club to offer tips for navigating all the new and existing treatment options for patients with moderate to severe psoriasis. With so many effective options on the market, Dr. Boh says it's possible to find the best fit fWhere are You Getting Your Asset Protection Advice?
https://practicaldermatology.com/topics/practice-management/where-are-you-getting-your-asset-protection-advice/20344/Your CPA may be mistaken.Finding and Taking Advantage of Your Employees' Strengths
https://practicaldermatology.com/topics/practice-management/finding-and-taking-advantage-of-your-employees-strengths/20435/Tips for successfully incorporating a strength-based approach to staff management.Dupixent, Juvéderm Vollure XC, Bavencio Approvals
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-dupixent-juv-derm-vollure-xc-bavencio-approvals/18698/The FDA has approved Regeneron's injectable Dupixent (dupilumab) to treat adults with moderate-to-severe eczema. It will be marketed by Regeneron and Sanofi Genzyme in the US. Allergan's Juvéderm Vollure XC has received FDA approval based on a pivotal clinical trial in which 59 percent of subjects sUpdates on NMSC, Zika, Aesthetics from Summer AAD Meeting
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-updates-on-nmsc-zika-aesthetics-from-summer-aad-meeting/18735/From the dermatologist's role in preparing for Zika to the latest advancements in aesthetics, the Summer meeting of the American Academy of Dermatology in Boston offered fresh insights for practitioners. Get updates on AK Management, the Zika risk, dermatologic care for nursing mothers, fillers, andTelemedicine and Access, Inappropriate Antibiotics, Industry Growth
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-telemedicine-and-access-inappropriate-antibiotics-industry-growth/18602/New research published online in JAMA Dermatology suggests that teledermatology improves access to care. Experts predict continued growth of telemedicine in dermatology. New estimates suggest that 30% of antibiotic prescriptions may be inappropriate. Dermatologists warn against antibiotic misuse andTreatment Considerations for Hyperpigmentation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/treatment-considerations-for-hyperpigmentation/18830/Seemal R. Desai, MD and Marta I. Rendon, MD discuss their treatment protocols for hyperpigmentation—from prescriptions and cosmeceuticals to lasers and peels. Noting that hyperpigmentation is a chronic, life-long condition, they emphasize the importance of vehicle consideration in enhancing efficacyMelasma Treatments: A Review of Laser Therapies and the Integration of Reflectance Confocal Microscopy
https://practicaldermatology.com/topics/general-topics/melasma-treatments-a-review-of-laser-therapies-and-the-integration-of-reflectance-confocal-microscopy/21363/Reflectance confocal microscopy may play a role in melasma stratification and treatment assessment.